RU94040166A - Способ получения производных тирозина - Google Patents

Способ получения производных тирозина

Info

Publication number
RU94040166A
RU94040166A RU94040166/04A RU94040166A RU94040166A RU 94040166 A RU94040166 A RU 94040166A RU 94040166/04 A RU94040166/04 A RU 94040166/04A RU 94040166 A RU94040166 A RU 94040166A RU 94040166 A RU94040166 A RU 94040166A
Authority
RU
Russia
Prior art keywords
heteroatoms
substituent
alkyl
rrepresents
tyrosine
Prior art date
Application number
RU94040166/04A
Other languages
English (en)
Other versions
RU2097377C1 (ru
Inventor
И.А. Чанг Джон
Us]
Л. Хьюджес Дэвид
Зао Дэлиан
Cn]
Original Assignee
Мерк Энд Ко.
Мерк Энд Ко., Инк.
Инк. (US)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Энд Ко., Мерк Энд Ко., Инк., Инк. (US) filed Critical Мерк Энд Ко.
Publication of RU94040166A publication Critical patent/RU94040166A/ru
Application granted granted Critical
Publication of RU2097377C1 publication Critical patent/RU2097377C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Изобретение представляет собой высокоэффективный способ синтеза соединений формулы, приведенной в описании, где заместитель Rпредставляет собой шестичленное насыщенное или ненасыщенное гетероциклическое кольцо, содержащее один или два гетероатома, где гетероатомы представляют собой атом N, или NR, где R- водород или C- C-алкил, m принимает целые значения от двух до шести, заместитель R- арил, C- C-алкил или C- C-аралкил.

Claims (1)

  1. Изобретение представляет собой высокоэффективный способ синтеза соединений формулы, приведенной в описании, где заместитель R1 представляет собой шестичленное насыщенное или ненасыщенное гетероциклическое кольцо, содержащее один или два гетероатома, где гетероатомы представляют собой атом N, или NR6, где R6 - водород или C1 - C10-алкил, m принимает целые значения от двух до шести, заместитель R4 - арил, C1 - C10-алкил или C4 - C10-аралкил.
RU9494040166A 1992-02-28 1993-02-23 Способ получения производных тирозина RU2097377C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/843,658 US5206373A (en) 1992-02-28 1992-02-28 Process for preparing fibrinogen receptor antagonists
US843,658 1992-02-28
PCT/US1993/001646 WO1993016995A1 (en) 1992-02-28 1993-02-23 Process for preparing fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
RU94040166A true RU94040166A (ru) 1996-07-10
RU2097377C1 RU2097377C1 (ru) 1997-11-27

Family

ID=25290632

Family Applications (2)

Application Number Title Priority Date Filing Date
RU96107890A RU2114105C1 (ru) 1992-02-28 1993-02-23 4-(4-пиридил)бутиловый эфир n-сульфонилтирозина или его фармацевтически приемлемые соли и способ получения 4-(4-пиперидил)бутилового эфира n-сульфонилтирозина или его фармацевтически приемлемых солей
RU9494040166A RU2097377C1 (ru) 1992-02-28 1993-02-23 Способ получения производных тирозина

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU96107890A RU2114105C1 (ru) 1992-02-28 1993-02-23 4-(4-пиридил)бутиловый эфир n-сульфонилтирозина или его фармацевтически приемлемые соли и способ получения 4-(4-пиперидил)бутилового эфира n-сульфонилтирозина или его фармацевтически приемлемых солей

Country Status (25)

Country Link
US (1) US5206373A (ru)
EP (2) EP0558139B1 (ru)
JP (1) JP2674679B2 (ru)
KR (1) KR100187779B1 (ru)
CN (1) CN1050832C (ru)
AR (1) AR247878A1 (ru)
AT (1) ATE156118T1 (ru)
AU (2) AU3732293A (ru)
CA (1) CA2090509C (ru)
CZ (1) CZ283485B6 (ru)
DE (1) DE69312528T2 (ru)
DK (1) DK0558139T3 (ru)
ES (2) ES2156255T3 (ru)
FI (1) FI106023B (ru)
GR (2) GR3024965T3 (ru)
HU (2) HU226957B1 (ru)
LV (1) LV12824B (ru)
MX (1) MX9301045A (ru)
NZ (1) NZ249751A (ru)
RO (1) RO116016B1 (ru)
RU (2) RU2114105C1 (ru)
SK (1) SK281250B6 (ru)
TW (1) TW229206B (ru)
WO (1) WO1993016995A1 (ru)
YU (1) YU49077B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264813B1 (it) * 1993-07-28 1996-10-10 Oxon Italia Spa Procedimento per la preparazione di alcansolfonammidi
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5980951A (en) * 1996-04-10 1999-11-09 Merck & Co., Inc. Oral coated active drugs
EP0925063A4 (en) 1996-07-01 2000-12-27 Lilly Co Eli Blood-glucose-lowering and lipid-lowering compounds
GB9812088D0 (en) * 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
CN1330636C (zh) * 2005-09-26 2007-08-08 鲁南制药集团股份有限公司 盐酸替罗非班中间体的合成方法
CN102452975A (zh) * 2010-11-01 2012-05-16 天津康鸿医药科技发展有限公司 盐酸替罗非班中间体合成方法
CN104447509B (zh) * 2013-09-18 2016-08-24 嘉实（湖南）医药科技有限公司 一种盐酸替罗非班的制备工艺
CN108440393A (zh) * 2018-03-20 2018-08-24 成都倍特药业有限公司 替罗非班物料杂质、杂质制备及物料中杂质检测方法
CN109608387A (zh) * 2019-01-02 2019-04-12 海门慧聚药业有限公司 盐酸替罗非班的制备
CN111100066B (zh) * 2019-11-29 2021-07-30 石药集团恩必普药业有限公司 一种盐酸替罗非班中间体及盐酸替罗非班的制备方法
CN112816282B (zh) * 2020-12-29 2022-04-12 江苏慧聚药业股份有限公司 一种盐酸替罗非班的有关物质及其制备和检测方法
CN115181058B (zh) * 2021-04-01 2024-06-11 武汉武药科技有限公司 组合物及其质量控制方法
CN114315697A (zh) * 2021-12-20 2022-04-12 河北国龙制药有限公司 一种盐酸替罗非班的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756713A (en) * 1953-07-06 1956-09-05 Ciba Ltd Substituted piperidines and process of making them
GB772516A (en) * 1953-12-22 1957-04-17 Ciba Ltd Piperidines and process of making same
GB939019A (en) * 1959-01-19 1963-10-09 Aspro Nicholas Ltd Diphenyl methane derivatives and methods for the preparation thereof
IT1062206B (it) * 1974-02-01 1983-09-20 Rotta Research Lab S P A A S Derivati della tirosina attivi sulla muscolatura liscia
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
LV12824B (en) 2002-09-20
AU657199B2 (en) 1995-03-02
SK281250B6 (sk) 2001-01-18
FI106023B (fi) 2000-11-15
DE69312528D1 (de) 1997-09-04
AR247878A1 (es) 1995-04-28
CN1050832C (zh) 2000-03-29
AU3383693A (en) 1993-09-02
GR3024965T3 (en) 1998-01-30
DK0558139T3 (da) 1997-09-01
AU3732293A (en) 1993-09-13
HU9600658D0 (en) 1996-05-28
RU2114105C1 (ru) 1998-06-27
YU49077B (sh) 2003-08-29
LV12824A (en) 2002-05-20
NZ249751A (en) 1996-06-25
CA2090509C (en) 1997-02-25
JPH069557A (ja) 1994-01-18
DE69312528T2 (de) 1998-02-19
CA2090509A1 (en) 1993-08-29
FI943933A (fi) 1994-10-04
SK102294A3 (en) 1995-04-12
YU13193A (sh) 1997-07-31
EP0738714B1 (en) 2001-05-02
EP0738714A3 (en) 1996-11-20
EP0738714A2 (en) 1996-10-23
CZ283485B6 (cs) 1998-04-15
KR950700252A (ko) 1995-01-16
ES2105069T3 (es) 1997-10-16
WO1993016995A1 (en) 1993-09-02
MX9301045A (es) 1993-09-01
GR3035827T3 (en) 2001-08-31
HU9402467D0 (en) 1994-10-28
RO116016B1 (ro) 2000-09-29
CN1076441A (zh) 1993-09-22
ATE156118T1 (de) 1997-08-15
EP0558139A1 (en) 1993-09-01
CZ203394A3 (en) 1995-10-18
FI943933A0 (fi) 1994-08-26
EP0558139B1 (en) 1997-07-30
KR100187779B1 (ko) 1999-06-01
TW229206B (ru) 1994-09-01
HUT70537A (en) 1995-10-30
HU226957B1 (en) 2010-03-29
US5206373A (en) 1993-04-27
ES2156255T3 (es) 2001-06-16
HU217959B (hu) 2000-05-28
JP2674679B2 (ja) 1997-11-12
RU2097377C1 (ru) 1997-11-27

Similar Documents

Publication Publication Date Title
RU94040166A (ru) Способ получения производных тирозина
RU94046169A (ru) Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения
RU95101430A (ru) Производные 1-бифенилметилимидазола, их получение, фармацевтическая композиция, способ лечения или профилактики гипертонии
RU94040390A (ru) Производные виниленазаиндола, способ их получения, фармацевтическая композиция
RU94031155A (ru) Амидин - производные, способ их получения, их использование в качестве ингибиторов no - синтазы, фармсостав, способ лечения
ES484317A1 (es) Procedimiento para la obtencion de derivados de pirido (4,3-b)-carbazoles (elipticinas) sustituidos en posicion 1 por una cadena poliaminada
RU94041212A (ru) Способ получения производных 0-[4-(4-пиперидинил)бутил]тирозина
Sakaino et al. Structures and Chromotropic Properties of 1, 4-bis (4, 5-diphenylimidazol-2-yl) benzene Derivatives
RU94034117A (ru) Производные азола, способы их получения и антигрибковое средство
DE60229054D1 (de) Synthese von zyklopentadien derivaten
RU95100758A (ru) ПРОИЗВОДНЫЕ α - ПИРИМИДИНИЛАКРИЛОВОЙ КИСЛОТЫ
ATE98253T1 (de) Synthese von 6-methylenandrosta-1,4-dien-3,17dion-derivate.
RU94046458A (ru) Новые аналоги витамина d, способ получения, фармацевтическая композиция, способ лечения
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
FI940731A (fi) Amiditetratsolit ACAT-inhibiitoreina
RU94033098A (ru) Способ производных 1-замещенного-5/4h/-тетразолинона
UA26400C2 (uk) Спосіб одержаhhя похідhого ерголіhу
IT1201454B (it) 1,4-diidropiridine-2-sostituite
AR013183A1 (es) Procedimiento para producir un compuesto derivado de indol, compuestos obtenidos e intermediarios
FI974435A (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-klooripyridiineiksi
FI852951A0 (fi) Kemisk syntes.
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
Achini et al. Synthesis of pyrrolidines by intramolecular carbanionic epoxide opening
ATE1008T1 (de) Isomerisation von 3-azabi cyclo(3.1.0)hexan-derivaten.
ATE90331T1 (de) Herstellung von derivaten der glutarsaeure.

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120224